15 January 2004 : Original article
Human Omentum Majus as A Potential Source of Osteogenic Cells for Tissue Engineering (preliminary report)
P Kowalczyk, R M Olkowski, E Sienkiewicz-Latka, W Lisik, M Sinski, M Kosieradzki, Z Wierzbicki, J Przybylski, M Lewandowska-SzumielAnn Transplant 2004; 9(1A): 61-63 :: ID: 15636
Abstract
For the skeletal tissue engineering autologous stem cells are obtained from the bone marrow (BM). However, BM procurement procedures may be painful and may yield low number of stem cells upon processing. There is a need for other convenient stem cells sources.
The omentum majus is potential source of mesenchymal tissues. Thus the aim of this study was to determine if stem cells potentially present in human omentum majus could differentiate into osteogenic tissue. The observations were also performed in the presence of chosen biomaterials (steel, titanium, alumina, hydroxyapatite).
Collected cells were incubated on 96 wells plate (15000 cells per well) per one week in control media (i.e. DMEM + 10% FBS) without vitamin C and with vitamin C, and media enriched with: vitamin D3, dexamethasone. Human osteoblasts were used as a control. Osteocalcin level and alkaline phosphatase activity were compared between groups. Our results suggest that in humans, the omentum majus adipose tissue is able to respond to vitamin C, vitamin D3 and dexamethasone in a manner similar to osteoblasts. The results were confirmed on several chosen biomaterials. It suggests that these cells may express an osteoblast-like phenotype. Thus omentum may be taken into account as potential source of stem cells for skeletal reconstruction.
Keywords: Tissue Engineering, Mesenchymal Stem Cells, Omentum Majus, Osteoblasts
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860